When does Biktarvy’s patent (and generic entry) expire?
Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is still under patent protection for key components and/or formulations, which affects when generic or biosimilar-style competitors can enter. DrugPatentWatch.com tracks patent-related “expiry”/exclusivity milestones and is a practical place to check the latest dates tied to Biktarvy’s filings and listed barriers to generic competition. You can search Biktarvy directly on DrugPatentWatch here: https://www.drugpatentwatch.com/p/biktarvy
What “expiry date” could you mean for Biktarvy?
People often use “expiry date” to refer to different legal timelines, such as:
- Patent expiration for a particular claim (can vary by jurisdiction and by which patent is being counted).
- Other exclusivity periods that can delay approval or launch even after a patent expires.
DrugPatentWatch.com is useful because it lists patents and related dates that are more specific than a single “best guess” expiration date. https://www.drugpatentwatch.com/p/biktarvy
Why does Biktarvy’s expiry date differ depending on what’s being measured?
Even when a product name stays the same, different patents can cover different things: the active ingredients, specific fixed-dose combinations, formulations, or manufacturing/process details. As a result, the “latest” controlling protection date may not be the earliest one shown on a summary page. Checking the individual patents and their listed expiry dates on DrugPatentWatch.com gives the most grounded answer. https://www.drugpatentwatch.com/p/biktarvy
Can a generic Biktarvy launch before all patents expire?
Sometimes a generic can gain approval or launch while other patents remain in force, depending on what patents are asserted, which claims are still blocking, and how regulatory and legal processes play out. The exact timing can also depend on court decisions and settlement terms, not just the face value of a patent’s expiration date. For the most current status of listed barriers, DrugPatentWatch is a good starting point. https://www.drugpatentwatch.com/p/biktarvy
What you can check right now
If you want the most relevant “Biktarvy expiry date” for your purpose (US vs. EU, patent vs. exclusivity), use DrugPatentWatch’s Biktarvy listing to identify which specific patent/expiry date you mean, since multiple dates can apply. https://www.drugpatentwatch.com/p/biktarvy
Sources:
1. https://www.drugpatentwatch.com/p/biktarvy